APA (7th ed.) Citation

G, M., O, K., IY, P., K, S., BG, G., M, A., . . . KJ, M. (2026). Properdin deficiency or anti-properdin treatment ameliorates disease in the C3 gain-of-function mouse model of atypical haemolytic uraemic syndrome. Frontiers in immunology, 17, 1828298. https://doi.org/10.3389/fimmu.2026.1828298

Chicago Style (17th ed.) Citation

G, Mallett, et al. "Properdin Deficiency or Anti-properdin Treatment Ameliorates Disease in the C3 Gain-of-function Mouse Model of Atypical Haemolytic Uraemic Syndrome." Frontiers in Immunology 17 (2026): 1828298. https://doi.org/10.3389/fimmu.2026.1828298.

MLA (9th ed.) Citation

G, Mallett, et al. "Properdin Deficiency or Anti-properdin Treatment Ameliorates Disease in the C3 Gain-of-function Mouse Model of Atypical Haemolytic Uraemic Syndrome." Frontiers in Immunology, vol. 17, 2026, p. 1828298, https://doi.org/10.3389/fimmu.2026.1828298.